Functional characterization of the human CYP1A1 negative regulatory element: Modulation of Ah receptor mediated transcriptional activity

Carcinogenesis

Volumn 19, Issue 5, 1998, Pages 771-780

  Piechocki, Marie P ^a   Hines, Ronald N ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; CYTOCHROME P450; PALINDROMIC DNA; REPRESSOR PROTEIN; UNSPECIFIC MONOOXYGENASE;

ARTICLE; EXPRESSION VECTOR; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; REPORTER GENE; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BENZOFURANS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYTOCHROME P-450 CYP1A1; DNA PROBES; ENZYME INDUCTION; HUMANS; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); RECEPTORS, ARYL HYDROCARBON; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031819422     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.5.771     Document Type: Article

References (60)

1. Gonzalez, F.J. (1990) Molecular genetics of the P-450 superfamily. Pharmac. Ther., 45, 1-38.
2. Nelson,D.R., Koymans,L., Kamataki,T. et al. (1996) P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1-42.
3. Song,B.-J., Gelhoin,H.V., Park,S.S., Tsokos,G.C. and Friedman,F.K. (1985) Monoclonal antibody-directed radioimmunoassay detects cytochrome P-450 in human placenta and lymphocytes. Science, 228, 490-492.
4. Diaz,D., Fabre,I., Daujat,M., Saint Auhert,B., Bories,P., Michel,H. and Maurel,P. (1990) Omeprazole is an aryl hydrocarhon-like inducer of human hepatic cytochrome P450. Gastroenterology, 99, 737-747.
5. Ledirac,N., Delescluse,C., De Sousa,G., Pralavorio,M., Lesca,P., Amichot,M., Berg,J.B. and Rahmani,R. (1997) Carbaryl induces CYPIAI gene expression in HepG2 and HaCaT cells hut is not a ligand of the human hepatic Ah receptor. Toxicol. Appl. Pharmacol., 144, 177-182.
6. Hines,R.N., Piechocki,M.P. and Boucher,P.D. (1993) Molecular mechanisms controlling CYPIA gene expression. In Ruckpaul,K. and Rein,H. (eds) Frontiers in Biotransformation: Regulation and Control of Complex Biological Processes by Biotransformation. Akademie Verlag, Berlin, pp. 85-110.
7. Kouri,R.E. and Nehert,D.W. (1977) Genetic regulation of susceptibility to polycyclic aromatic hydrocarbon-induced tumors in the mouse. In Hiatt,H.H., Watson,J.D. and Winsten,J.A. (eds) Origins of Human Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 811-835.
8. Hayashi,S., Watanabe,J., Nakachi,K., Eguchi,H., Gotoh,O. and Kawajiri,K. (1994) Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis, 15, 801-806.
9. Catteau,A., Couriez,E., Beaune,P., Poisson,N., Bonaiti-Pellie,C. and Laurent,P. (1995) Genetic polymorphism of induction of CYP1A1 (EROD) activity. Pharmacogenetics, 5, 110-119.
10. Nebert,D.W., McKinnon,R.A. and Puga,A. (1996) Human drugmetabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer. DNA Cell Biol., 15, 273-280.
11. Kellermann,G., Luyten-Kellermann,M. and Shaw,C.R. (1973) Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am. J. Hum. Genet., 25, 327-331.
12. Kouri,R.E., McKinney,C.E., Slomiany,D.J., Snodgrass,D.R., Wray,N.P. and McLemore,T.L. (1982) Positive correlations between high aryl hydrocarbon hydroxylase activity and presence of lung cancer - analysis of cryopreserved lymphocytes. Cancer Res., 42, 5030-5037.
13. Anttila,S., Hirvonen,A., Husgafvel-Pursiainen,K., Karjalainen,A., Nurminen,T. and Vainio,H. (1994) Combined effect of CYPIAI inducibility and GSTM1 polymorphism on histological type of lung cancer. Carcinogenesis, 15, 1133-1136.
14. Alexandrov,K., Rojas,M., Kadlubar,F.F., Lang,N.P. and Bartsch,H. (1996) Evidence of anti-benzo[α]pyrene diolepoxide-DNA adduct formation in human colon mucosa. Carcinogenesis, 17, 2081-2083.
15. Bartsch,H., Rojas,M., Alexandrov,K. et al. (1995) Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humans. Pharmacogenetics, 5, S84-90.
16. 32P-postlabeling assay. J. Natl Cancer Inst., 81, 341-347.
17. Bartsch,H., Castegnaro,M., Rojas,M., Camus,A.-M., Alexandrov,K. and Lang,M. (1992) Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer. Toxicol. Lett., 64-65, 477-483.
18. McLemore,T.L., Adelberg,S., Czerwinski,M., Hubbard,W.C., Yu,S.J., Storeng,R., Wood,T.G., Hines,R.N. and Boyd,M.R. (1989) Altered regulation of the cytochrome P4501A1 gene: Novel inducer-independent gene expression in pulmonary carcinoma cell lines. J. Natl Cancer Inst., 81, 1787-1794.
19. Pyykk',K., Tuimala,R., Aalto,L. and Perki,T. (1991) Is aryl hydrocarbon hydroxylase activity a new prognostic indicator for breast cancer. Br. J. Cancer, 63, 596-600.
20. Murray,G.I., Weaver,R.J., Paterson,P.J., Ewen,S.W.B., Melvin,W.T. and Burke,M.D. (1993) Expression of xenobiotic metabolizing enzymes in breast cancer. J. Pathol., 169, 347-353.
21. Whitlock,J.P.Jr (1986) The regulation of cytochrome P-450 gene expression. Annu. Rev. Pharmacol. Toxicol., 26, 333-370.
22. Burbach,K.M. Poland,A. and Bradtield,C.A. (1992) Cloning of the Ahreceptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl Acad. Sci. USA, 89, 8185-8189.
23. Chen,H.-S.and Perdew,G.H. (1994) Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. J. Biol. Chem., 269, 27544-27558.
24. Hord,N.G. and Perdew,G.H. (1994) Physicochemical and immunocytochemical analysis of the aryl hydrocarbon receptor nuclear translocator: Characterization of two monoclonal antibodies to the aryl hydrocarbon receptor nuclear translocator. Mol. Pharmacol., 46, 618-626.
25. Reyes,H., Reisz-Porszasz,S. and Hankinson,O. (1992) Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science, 256, 1193-1195.
26. Singh,S.S., Hord,N.G. and Perdew,G.H. (1996) Characterization of the activated form of the Aryl hydrocarbon receptor in the nucleus of HeLa cells in the absence of exogenous ligand. Arch. Biochem. Biophys., 329, 47-55.
27. Probst,M.R., Reisz-Porszasz,S., Agbunag,R.V, Ong,M.S. and Hankinson,O. (1993) Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Mol. Pharmacol., 44, 511-518.
28. Swanson,H.I., Chan,W.K. and Bradfield,C.A. (1995) DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J. Biol. Chem., 270, 26292-26302.
29. Morgan,J.E. and Whitlock,J.P.Jr (1992) Transcription-dependent and transcription-independent nucleosome disruption induced by dioxin. Proc. Natl Acad. Sci. USA, 89, 11622-11626.
30. Okino,S.T. and Whitlock,J.P.Jr (1995) Dioxin induces localized, graded changes in chromatin structure: Implications for CYP1A1 gene transcription. Mol. Cell. Biol., 15, 3714-3721.
31. Ko,H.P, Okino,S.T., Ma,Q. and Whitlock,J.P.Jr (1996) Dioxin-induced CYP1A1transcription in vivo: The aromatic hydrocarbon receptor mediates transactivation, enhancer promoter communication, and changes in chromatin structure. Mol. Cell. Biol., 16, 430-436.
32. Hines,R.N., Mathis,J.M. and Jacob,C.S. (1988) Identification of multiple regulatory elements on the human cytochrome P450IA1 gene. Carcinogenesis, 9, 1599-1605.
33. Boucher,P.D., Ruch,R.J. and Hines,R.N. (1993) Specific nuclear protein binding to a negative regulatory element on the human CYP1A1 gene. J. Biol. Chem., 268, 17384-17391.
34. Boucher,P.D., Piechocki,M.P. and Hines,R.N. (1995) Partial characterization of the human CYP1A1 negatively acting transcription factor and mutational analysis of its cognate DNA recognition sequence. Mol. Cell. Biol., 15, 5144-5151.
35. Aden,D.P. Fogel,A., Plotkin,S., Damjanov,I. and Knowles,B.B. (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinomaderived cell line. Nature, 282, 615-616.
36. Hanahan,D. (1983) Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol., 166, 557-580.
37. Tartof,K.D. and Hobbs,C.A. (1988) New cloning vectors and techniques for easy and rapid restriction mapping. Gene, 67, 169-182.
38. Piechocki,M.P. and Hines,R.N. (1994) Oligonucleotide design and optimized protocol for site-directed mutagenesis. BioTechniques, 16, 701-707.
39. Sanger,E, Nicklen,S. and Coulson,A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA, 74, 5463-5467.
40. Shi,Y., Seto,E., Chang,L. and Shenk,T. (1991) Transcriptional repression by YY1, a human GLI-Kruppel-related protein and relief of repression by adenovirus E1A protein. Cell, 67, 377-388.
41. Natesan,S. and Oilman,M.Z. (1993) DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev., 7, 2497-2509.
42. Chodosh,L.A. (1988) Mobility shift DNA-binding assay using gel electrophoresis. In Ausubel,F.M. Brent,R., Kingston,R.E., Moore,D.D., Seidman,J.G., Smith,J.A. and Struhl,K. (eds) Current Protocols in Molecular Biology. Greene Publishing and Wiley-Interscience, New York, pp. 12.2.1-12.2.10.
43. Smith,P.K., Krohn,R.I., Hermanson,G.T., Mallia,A.K., Garner,F.H., Provenzano,M.D., Fujimoto,E.K., Goeke,N.M., Olson,B.J. amd Klenk,D.C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76-85.
44. Felgner,P.L., Gadek,T.R., Holm,M., Roman,R., Chan,H.W., Wenz,M., Northrop,J.P. Ringold,G.M. and Danielson,M. (1987) Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA, 84, 7413-7417.
45. Rose,J.K., Buonocore,L. and Whitt,M.A. (1991) A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. BioTechniques, 10, 520-525.
46. Chomczynski,P. and Sacchi,N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
47. Thompson,J. and Gillespie,D.H. (1987) Molecular hybridization with RNA probes in concentrated solutions of guanidine thiocyanate. Anal. Biochem., 163, 281-291.
48. Kellermann,G., Shaw,C.R. and Luyten-Kellerman,M. (1973) Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med., 298, 934-937.
49. Murray,G.I., Foster,C.O., Barnes,T.S., Weaver,R.J., Ewen,S.W.B., Melvin,W.T. and Burke,M.D. (1991) Expression of cytochrome P450IA in breast cancer. Br. J. Cancer, 63, 1021-1023.
50. McLemore,T.L., Adelberg,S., Liu,M.C. et al. (1990) Expression of CYP1A1 gene in patients with lung cancer: Evidence for cigarette smoke-induced expression in normal lung tissue and altered gene regulation in primary pulmonary carcinomas. J. Natl Cancer Inst., 82, 1333-1339.
51. Perera,F.R. Dickey,C., Santella,R. et al. (1994) Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis, 15, 2905-2910.
52. Petruzzelli,S., Camus,A.-M., Carrozzi,L. et al. (1988) Long-lasting effect of tobacco smoking on pulmonary drug-metabolizing enzymes: A casecontrol study on lung cancer patients. Cancer Res., 48, 4695-4700.
53. Kawajiri,K., Nakachi,K., Imai,K., Watanabe,J. and Hayashi,S. (1993) The CYP1A1 gene and cancer susceptibility. CRC Crit. Rev. Oncol. Hematol., 14, 77-87.
54. Spurr,N.K., Gough,A.C, Stevenson,K. and Wolf,C.R. (1987) MspI polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res., 15, 5901
55. Cosma,G., Crofts,F., Currie,D., Wirgin,I., Toniolo,P. and Garte,S.J. (1993) Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene. Cancer Epidemiol. Biomark. Prev., 2, 53-57.
56. Crofts,F., Taioli,E., Trachman,J., Cosma,G.N., Currie,D., Toniolo,P. and Garte,S.J. (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15, 2961-2963.
57. Shields,P.G., Bowman,E.D., Harrington,A.M., Doan,V.T. and Weston,A. (1993) Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res., 53, 3486-3492.
58. Trell,L., Korsgaard,R., Janzon,L. and Trell,E. (1985) Distribution and reproducibility of aryl hydrocarbon hydroxylase inducibility in a prospective population study of middle-aged male smokers and nonsmokers. Cancer, 56, 1988-1994.
59. Wu,L. and Whitlock,J.P.Jr (1992) Mechanism of dioxin action: Ah receptor-mediated increase in promoter accessibility in vivo. Proc. Natl Acad. Sci.USA, 89, 4811-4815.
60. Boucher,P.D. and Mines,R.N. (1995) In vitro binding and functional studies comparing the human CYP1A1 negative regulatory element with the orthologous sequences from rodent genes. Carcinogenesis, 16, 383-392.